Spero Therapeutics files initial beneficial ownership statement for director William Ho
SPRO•Spero Therapeutics director William Ho filed an initial statement of beneficial ownership dated Nov. 10, 2026.
1. Ownership filing
William Ho, a director of Spero Therapeutics, filed an initial statement of beneficial ownership dated Nov. 10, 2026.
